|
Proto Labs, Inc. (PRLB) DCF Valuation
US | Industrials | Manufacturing - Metal Fabrication | NYSE
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Proto Labs, Inc. (PRLB) Bundle
Designed for accuracy, our Proto Labs, Inc. (PRLB) DCF Calculator enables you to evaluate Proto Labs, Inc. valuation using real-world financial data and offers complete flexibility to modify all essential parameters for improved projections.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 458.7 | 434.4 | 488.1 | 488.4 | 503.9 | 516.8 | 530.1 | 543.8 | 557.8 | 572.1 |
| Revenue Growth, % | 0 | -5.3 | 12.36 | 0.06146307 | 3.17 | 2.57 | 2.57 | 2.57 | 2.57 | 2.57 |
| EBITDA | 110.7 | 92.4 | 80.8 | 66.4 | 66.6 | 91.8 | 94.1 | 96.5 | 99.0 | 101.6 |
| EBITDA, % | 24.14 | 21.28 | 16.56 | 13.59 | 13.21 | 17.76 | 17.76 | 17.76 | 17.76 | 17.76 |
| Depreciation | 30.9 | 32.6 | 40.5 | 39.4 | 37.5 | 39.3 | 40.3 | 41.4 | 42.4 | 43.5 |
| Depreciation, % | 6.73 | 7.5 | 8.3 | 8.07 | 7.45 | 7.61 | 7.61 | 7.61 | 7.61 | 7.61 |
| EBIT | 79.9 | 59.8 | 40.3 | 26.9 | 29.1 | 52.4 | 53.8 | 55.2 | 56.6 | 58.0 |
| EBIT, % | 17.41 | 13.77 | 8.27 | 5.52 | 5.77 | 10.15 | 10.15 | 10.15 | 10.15 | 10.15 |
| Total Cash | 160.7 | 161.7 | 77.5 | 80.1 | 102.8 | 129.1 | 132.5 | 135.9 | 139.4 | 142.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 57.5 | 58.4 | 81.4 | 80.3 | 75.1 | 76.5 | 78.4 | 80.5 | 82.5 | 84.6 |
| Account Receivables, % | 12.52 | 13.45 | 16.67 | 16.43 | 14.9 | 14.8 | 14.8 | 14.8 | 14.8 | 14.8 |
| Inventories | 10.1 | 10.9 | 13.2 | 13.6 | 13.7 | 13.3 | 13.7 | 14.0 | 14.4 | 14.7 |
| Inventories, % | 2.2 | 2.5 | 2.7 | 2.78 | 2.71 | 2.58 | 2.58 | 2.58 | 2.58 | 2.58 |
| Accounts Payable | 16.8 | 18.2 | 25.4 | 17.4 | 15.6 | 20.4 | 20.9 | 21.4 | 22.0 | 22.6 |
| Accounts Payable, % | 3.66 | 4.2 | 5.2 | 3.55 | 3.1 | 3.94 | 3.94 | 3.94 | 3.94 | 3.94 |
| Capital Expenditure | -62.2 | -47.0 | -34.2 | -21.7 | -28.1 | -42.8 | -43.9 | -45.0 | -46.2 | -47.4 |
| Capital Expenditure, % | -13.57 | -10.82 | -7.01 | -4.44 | -5.58 | -8.28 | -8.28 | -8.28 | -8.28 | -8.28 |
| Tax Rate, % | 38.39 | 38.39 | 38.39 | 38.39 | 38.39 | 38.39 | 38.39 | 38.39 | 38.39 | 38.39 |
| EBITAT | 62.6 | 48.4 | 33.5 | 28.5 | 17.9 | 42.4 | 43.4 | 44.6 | 45.7 | 46.9 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -19.5 | 33.6 | 21.6 | 38.9 | 30.7 | 42.6 | 38.1 | 39.1 | 40.1 | 41.1 |
| WACC, % | 10.64 | 10.64 | 10.64 | 10.64 | 10.63 | 10.64 | 10.64 | 10.64 | 10.64 | 10.64 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 150.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 42 | |||||||||
| Terminal Value | 485 | |||||||||
| Present Terminal Value | 293 | |||||||||
| Enterprise Value | 443 | |||||||||
| Net Debt | -78 | |||||||||
| Equity Value | 521 | |||||||||
| Diluted Shares Outstanding, MM | 26 | |||||||||
| Equity Value Per Share | 19.87 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real PRLB financials.
- Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effect of your inputs on Proto Labs' valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Customizable Forecast Inputs: Adjust essential metrics such as revenue growth, profit margins, and capital investments.
- Instant DCF Valuation: Automatically computes intrinsic value, NPV, and other financial metrics in real-time.
- High-Precision Accuracy: Leverages Proto Labs' actual financial data for credible valuation results.
- Simplified Scenario Analysis: Easily evaluate various assumptions and analyze different outcomes.
- Efficiency Booster: Remove the hassle of creating intricate valuation models from the ground up.
How It Works
- Download the Template: Gain immediate access to the Excel-based PRLB DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates Proto Labs' intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial analysis.
Why Choose Proto Labs, Inc. (PRLB)?
- Accelerate Production: Streamlined processes allow for rapid prototyping and manufacturing.
- Enhance Quality: Advanced technology ensures high precision and reliability in every part.
- Fully Customizable Solutions: Tailor designs to meet your specific project requirements.
- User-Friendly Interface: Intuitive tools make it easy to navigate and manage your orders.
- Industry Expertise: Supported by a team of professionals dedicated to delivering exceptional service.
Who Should Use This Product?
- Investors: Evaluate Proto Labs, Inc.'s (PRLB) market position before making investment decisions.
- CFOs and Financial Analysts: Optimize valuation methodologies and assess growth projections.
- Startup Founders: Understand the valuation metrics of successful companies like Proto Labs, Inc. (PRLB).
- Consultants: Create comprehensive valuation reports for client projects.
- Students and Educators: Utilize current data to learn and teach valuation strategies.
What the Template Contains
- Pre-Filled DCF Model: Proto Labs, Inc. (PRLB) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Proto Labs, Inc. (PRLB) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.